There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

We addressed the Trump administration’s concerns about fentanyl trafficking and appointed a “fentanyl czar” (who hasn’t been ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

The proposed tariffs come amid growing pressure from pharmaceutical lobby groups in the US for Trump for changes Australian drug prices.

The ClearBridge Appreciation Strategy underperformed the benchmark S&P 500 Index in the second quarter. On an absolute basis, ...

Local government employees will face a 36.5% increase in premiums as the health plan continues its 'death spiral,' as many ...

A restriction on the supply of generic medicines to Australia is among genuine risks, regardless of the eventual tariff on ...

Texas State Senator Angela Paxton has filed for divorce from her husband, Republican state Attorney General Ken Paxton, who ...

A leading Irish logistics company has announced multi-million euro plans to develop a new inland port facility in the capital ...

Izquierdo is a lawful permanent legal resident of the United States, but was scooped up and deported on extremely short ...